Paulson Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-102
Closed -$5K 613
2017
Q4
$5K Buy
+102
New +$5.58K ﹤0.01% 456

Other funds holding BIVV

Paulson Wealth Management's BIVV Position: Q1 2018 in Review

Paulson Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 102 shares — an estimated $5K sold.

Paulson Wealth Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Paulson Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Paulson Wealth Management sold 102 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5K.
  • Paulson Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Paulson Wealth Management's Bioverativ Inc. Common Stock position peaked at $5K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Paulson Wealth Management's 13F filing for Q1 2018, filed 2 May 2018.